Article

Transcriptomic Profiling MicroRNA and Non-Coding RNA from Whole Blood in African Americans with MASLD

2025-12-25

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern, yet the role of non-coding RNAs (ncRNAs), including microRNAs (miRNAs), in its pathogenesis remains poorly understood. In this pilot study, we aimed to identify significantly expressed miRNAs and ncRNAs and correlate transcriptomic patterns of the findings with previously identified coding gene expression profiles to expl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b25c6bd9-ec0e-5171-a8b9-b59e40309ff8
DOI: 10.20944/preprints202506.0499.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptomic Profiling MicroRNA and Non-Coding RNA from Whole Blood in African Americans with MASLDDOI 10.20944/preprints202506.0499.v2Read

Transcriptomic Profiling MicroRNA and Non-Coding RNA from Whole Blood in African Americans with MASLDSemantic proximity Read

Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †Semantic proximity Read

Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome AnalysisSemantic proximity Read

Differences in gene expression may contribute to the racial differences in the risk of MASLD.Semantic proximity Read

Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read

High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease–related fibrosisSemantic proximity Read

Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progressionSemantic proximity Read

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesSemantic proximity Read

Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targetsSemantic proximity Read

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular DiseaseSemantic proximity Read

MicroRNAs in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesSemantic proximity Read